Found: 39
Select item for more details and to access through your institution.
Corrigendum to Hyperpigmentation due to imatinib: A rare case of cutaneous involvement.
- Published in:
- 2020
- Publication type:
- Correction Notice
Correction to A fatal case of Immune thrombocytopenia secondary to the immune checkpoint inhibitor ipilimumab in a patient with BRAF wild type metastatic melanoma.
- Published in:
- 2020
- Publication type:
- Correction Notice
Descriptive comparison of hospital formulary decisions with published oncology valuation methods.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 891, doi. 10.1177/1078155219877927
- By:
- Publication type:
- Article
Durable response after interruption of nivolumab in patients with metastatic renal cell carcinoma: Is renal toxicity a marker to predict the benefit of nivolumab?
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 1000, doi. 10.1177/1078155219877923
- By:
- Publication type:
- Article
Voriconazole prophylaxis in leukemic patients: A retrospective single-center study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 873, doi. 10.1177/1078155219876683
- By:
- Publication type:
- Article
A systematic review: Role of systemic therapy on treatment and prevention of brain metastasis in renal cell carcinoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 972, doi. 10.1177/1078155220905648
- By:
- Publication type:
- Article
Pharmacological issues concerning olaparib capsule and tablet formulations in treating ovarian cancer: Are they really the same drug?
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 967, doi. 10.1177/1078155219900913
- By:
- Publication type:
- Article
Driving toward precision medicine for B cell lymphomas: Targeting the molecular pathogenesis at the gene level.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 943, doi. 10.1177/1078155219895079
- By:
- Publication type:
- Article
Administration sequence for multi-agent oncolytic regimens.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 933, doi. 10.1177/1078155219895070
- By:
- Publication type:
- Article
Evaluation of neutropenia-related outcomes in Hodgkin's lymphoma patients with moderate or severe neutropenia who received ABVD chemotherapy without using granulocyte-colony stimulating factor.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 929, doi. 10.1177/1078155219891663
- By:
- Publication type:
- Article
Bevacizumab-induced dysphonia: A case report with brief review of literature.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 1032, doi. 10.1177/1078155219889388
- By:
- Publication type:
- Article
Bicalutamide-associated hallucinations in a metastatic prostate cancer patient: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 1029, doi. 10.1177/1078155219886918
- By:
- Publication type:
- Article
Relapsed refractory metastatic squamous cell cancer of anal canal in a patient with retroviral infection responding to cetuximab.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 1025, doi. 10.1177/1078155219884605
- By:
- Publication type:
- Article
Safe use of nivolumab in a patient with renal cell carcinoma and hepatitis B.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 1022, doi. 10.1177/1078155219882071
- By:
- Publication type:
- Article
Angioedema late in the course of adjuvant nivolumab therapy for melanoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 1019, doi. 10.1177/1078155219881181
- By:
- Publication type:
- Article
How long should we continue crizotinib in ALK translocation-positive inflammatory myofibroblastic tumors? Long-term complete response with crizotinib and review of the literature.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 1011, doi. 10.1177/1078155219879757
- By:
- Publication type:
- Article
Development of pneumonitis after rituximab treatment in a patient with lymphoma.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
Fatal neutropenic enterocolitis associated with docetaxel use: A review of cases reported to the United States Food and Drug Administration Adverse Event Reporting System.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 923, doi. 10.1177/1078155219879494
- By:
- Publication type:
- Article
Olanzapine as a rescue antiemetic in hematopoietic stem cell transplant.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 918, doi. 10.1177/1078155219879215
- By:
- Publication type:
- Article
Pertuzumab-associated diarrhea in HER2/neu-positive breast cancer patients: A comparison of trials to actual practice.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 912, doi. 10.1177/1078155219879211
- By:
- Publication type:
- Article
Ruxolitinib for the treatment of lymphoma-associated hemophagocytic lymphohistiocytosis: A cautionary tale.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 1005, doi. 10.1177/1078155219878774
- By:
- Publication type:
- Article
Bone modifying agents for patients with bone metastases from breast cancer managed in routine practice setting: Treatment patterns and outcome.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 906, doi. 10.1177/1078155219877929
- By:
- Publication type:
- Article
Learning good manufacturing practices in an escape room: Validation of a new pedagogical tool.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 853, doi. 10.1177/1078155219875504
- By:
- Publication type:
- Article
Evaluation of the use of non-formulary oncology medications restricted to outpatient use in hospitalized patients after implementation of a criteria-for-use algorithm.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 882, doi. 10.1177/1078155219877920
- By:
- Publication type:
- Article
Behcet's-like syndrome following pembrolizumab: An immune-related adverse event associated with programmed death receptor-1 inhibitor therapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 995, doi. 10.1177/1078155219877219
- By:
- Publication type:
- Article
A rare case of primary rectal choriocarcinoma and review of the literature.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 989, doi. 10.1177/1078155219875510
- By:
- Publication type:
- Article
Clinical and economic impact of clinical pharmacist intervention in a hematology unit.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 866, doi. 10.1177/1078155219875806
- By:
- Publication type:
- Article
Cabozantinib use in metastatic renal cell carcinoma patients in clinical practice: Evaluation of dosing patterns, tolerability, and outcomes compared to clinical trials.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 861, doi. 10.1177/1078155219875509
- By:
- Publication type:
- Article
Impact of oral oncolytic initiation on medication adherence for pre-existing comorbid chronic conditions.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 835, doi. 10.1177/1078155219875206
- By:
- Publication type:
- Article
Radiation oncology outpatient medication management needs and service gaps – A cross-sectional study of patients and clinicians.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 846, doi. 10.1177/1078155219875210
- By:
- Publication type:
- Article
Peripheral neuropathy in non-Hodgkin's lymphoma patients receiving vincristine with and without aprepitant/fosaprepitant.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 809, doi. 10.1177/1078155219870840
- By:
- Publication type:
- Article
Metformin's effectiveness in preventing prednisone-induced hyperglycemia in hematological cancers.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 823, doi. 10.1177/1078155219873048
- By:
- Publication type:
- Article
Application of an innovative high-throughput liquid chromatography-tandem mass spectrometry method for simultaneous analysis of 18 hazardous drugs to rule out accidental acute chemotherapy exposures in health care workers.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 794, doi. 10.1177/1078155219870591
- By:
- Publication type:
- Article
The impact of corticosteroid use during anti-PD1 treatment.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 814, doi. 10.1177/1078155219872786
- By:
- Publication type:
- Article
Paroxetine for the treatment of intractable and persistent cough in patients diagnosed with cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 803, doi. 10.1177/1078155219870594
- By:
- Publication type:
- Article
Successful switch to oral tacrolimus in a patient with hypersensitivity reaction to parenteral vitamin K, cyclosporine, and tacrolimus: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 986, doi. 10.1177/1078155219869442
- By:
- Publication type:
- Article
Impact of an electronic health record transition on chemotherapy error reporting.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 787, doi. 10.1177/1078155219870590
- By:
- Publication type:
- Article
Efficacy of second-line targeted agents in kras wild metastatic colorectal cancer patients who received prior targeted agent: First anti-epidermal growth factor receptor or vascular endothelial growth factor in right and left colon?
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 781, doi. 10.1177/1078155219856682
- By:
- Publication type:
- Article
Cyclophosphamide desensitization in patients with severe hypersensitivity reactions to bendamustine.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 982, doi. 10.1177/1078155219867127
- By:
- Publication type:
- Article